Inhibikase Therapeutics, Inc. , a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain.
Inhibikase Therapeutics stock last closed at $0.60, down 7.69% from the previous day, and has decreased 58.9% in one year. It has underperformed other stocks in the Biotechnology industry by 0.35 percentage points. Inhibikase Therapeutics stock is currently +36.36% from its 52-week low of $0.44, and -60.53% from its 52-week high of $1.52.
As of Mar 20, 2023, there are 25.23M IKT shares outstanding. The market cap of IKT is $15.14M. In the past 24 hours, 403,776 IKT shares were traded.
How to Buy Inhibikase Therapeutics Stock
Not sure how to invest in Inhibikase Therapeutics stock? Here's how.
Figure out where to buy Inhibikase Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Inhibikase Therapeutics stock.
Deposit funds into your brokerage account: Choose your payment method and add your details.
Research Inhibikase Therapeutics stock: The Inhibikase Therapeutics ticker symbol is IKT. Is Inhibikase Therapeutics stock a good investment? Should you buy shares of IKT? How do IKT's underlying business fundamentals look? Do top analysts think Inhibikase Therapeutics is a good buy? Why has IKT's stock price moved recently? (Hint: Our stock market research tools can help you understand if IKT is a good stock to buy).
Execute your IKT purchase: Decide if you will purchase IKT shares at the current market price or use a limit order to purchase IKT shares at a specific price.
Keep an eye on your IKT investment: Create a watchlist to monitor your investment in Inhibikase Therapeutics shares.
Step 1: Figure out where to buy Inhibikase Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy IKT stock.
A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Technology to Financial Services, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.